Knopp Biosciences LLC
Industry: Biotechnology (See others in industry)
Address:
2100 Wharton Street, Suite 615
Pittsburgh, PA, 15203
Phone: 412-488-1776
Pittsburgh, PA, 15203
Phone: 412-488-1776
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2021-01-05 | New | $1 | $1 | Equity Only | 06b | SEC link |
| 2020-10-27 | Amended | $12,608,668 | $5,036,134 | Equity Only | 06b | SEC link |
| 2020-07-07 | New | $7,572,534 | $7,572,534 | Equity Only | 06b | SEC link |
| 2020-06-19 | Amended | $14,942,729 | $2,223,018 | Equity Only | 06b | SEC link |
| 2020-03-05 | New | $1,000,000 | $1,000,000 | Debt Only | 06b | SEC link |
| 2020-03-02 | Amended | $12,719,711 | $0 | Equity Only | 06b | SEC link |
| 2019-06-24 | Amended | $14,942,729 | $2,469,711 | Equity Only | 06b | SEC link |
| 2019-03-01 | Amended | $10,250,000 | $0 | Equity Only | 06b | SEC link |
| 2019-02-27 | New | $10,250,000 | $10,250,000 | Equity Only | 06b | SEC link |
| 2018-07-24 | Amended | $28,000,000 | $13,057,271 | Debt Only | 06b | SEC link |
| 2018-06-26 | Amended | $14,942,729 | $0 | Equity Only | 06b | SEC link |
| 2017-12-05 | Amended | $23,000,000 | $0 | Debt Only | 06b | SEC link |
| 2017-06-30 | Amended | $14,942,729 | $0 | Equity Only | 06b | SEC link |
| 2017-03-02 | Amended | $17,449,297 | $0 | Debt Only | 06b | SEC link |
| 2016-12-28 | Amended | $17,154,649 | $0 | Debt Only | 06b | SEC link |
| 2016-07-05 | Amended | $14,942,729 | $2,442,916 | Equity Only | 06b | SEC link |
| 2016-05-25 | Amended | $12,499,813 | $0 | Debt Only | 06b | SEC link |
| 2016-02-16 | Amended | $12,499,813 | $0 | Debt Only | 06b | SEC link |
| 2015-07-08 | Amended | $14,942,729 | $7,103,056 | Equity Only | 06b | SEC link |
| 2015-04-14 | Amended | $5,396,757 | $371,757 | Debt Only | 06b | SEC link |
| 2014-12-11 | Amended | $5,025,000 | $0 | Debt Only | 06b | SEC link |
| 2014-07-14 | Amended | $14,942,729 | $1,909,607 | Equity Only | 06b | SEC link |
| 2014-05-28 | Amended | $3,115,393 | $3,115,393 | Debt Only | 06b | SEC link |
| 2014-04-14 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2013-07-18 | Amended | $14,942,729 | $0 | Equity Only | 06 | SEC link |
| 2012-11-08 | Amended | $14,942,729 | $14,942,729 | Equity Only | 06 | SEC link |
| 2012-07-09 | New | Yet to Sell | $0 | Equity Only | 06 | SEC link |
| 2010-09-03 | New | $140,000,000 | $140,000,000 | Equity Only | 06 | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| C. David Adair | Director |
| Michael E. Bozik | Director, Executive, Promoter |
| Stephen E Butts | Director |
| Steven Dworetzky | Executive |
| Steve Dworetzky | Executive |
| Benjamin A. Gomez | Director |
| Valentin K. Gribkoff | Executive |
| Gregory T. Hebrank | Director, Executive, Promoter |
| Evan W. Ingersoll | Executive |
| Suresh Khemani | Executive |
| Shane Kovacs | Director |
| Mark Kreston | Executive |
| Frank J. Lucchino, Jr. | Executive |
| James Mather | Executive |
| Jeffrey S. Mc Cormick | Director |
| Thomas V. Petzinger Jr. | Director, Executive, Promoter |
| Thomas V. Petzinger, Jr. | Director, Executive, Promoter |
| Calman Prussin | Executive |